2012 Lung Cancer Research Foundation Annual Grant Program
Jim Dimitroulakos, PhD
Ottawa Hospital Research Institute
Research Project:
Activating Transcription Factor 3 as a novel mediator of platin induced turmour cell cytotoxcity and resistance
Summary:
Grant will study an important activating factor related to the activity and resistance of a commonly used chemotherapy drug for lung cancer called cisplatin. Better understanding of this effect could lead to improved outcomes using this agent.